Washington Trust Advisors, Inc.
Position in BTAIQ — BioXcel Therapeutics, Inc.
CIK 1900099
WELLESLEY, MA
Position in BTAIQ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$115
-$99 QoQ
Shares Held
82
-48.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 47 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAIQ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Washington Trust Advisors, Inc. holds $173,445 across 5 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #5 (0.1% of the industry book) .
All Filings in BTAIQ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115 | 82 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $214 | 160 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $256 | 160 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $409 | 160 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $289 | 160 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $324 | 160 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | — | 2,572 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | — | 2,572 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | — | 2,572 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | — | 2,572 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | — | 2,572 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | — | 1,250 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | — | 1,250 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | — | 1,250 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | — | 1,250 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | — | 1,250 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | — | 1,250 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | — | 250 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | — | 250 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||